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1. Introduction 
Cancer is the leading cause of death in economically developed countries and the second 
leading cause of death in developing countries.1 In developed counties, colorectal cancer is 
the second leading cause of cancer death in men and the third leading cause of cancer death 
in women.2 In developing countries, colorectal cancer is the fifth leading cause of cancer 
death in men and the sixth in women. Worldwide, colorectal cancer is the fourth leading 
cause of cancer death in men and the third in women.2 
The most promising treatment for colorectal cancer is curative surgery. However, some 
patients recur after curative resection.3 In order to detect and treat recurrent tumors earlier, 
a post-operative surveillance after curative resection for colorectal cancer is in clinical use, 
although an optimal surveillance system for patients with curative resection for colorectal 
cancer is still uncertain. 
In this chapter, we describe some topics concerning surveillance and characteristics of 
recurrence after curative resection for colorectal cancer as follows: 
i. historical review of surveillance  
ii. characteristics of recurrence  
iii. surveillance tools  
iv. recommended surveillance from European Society for Medical Oncology (ESMO), 
American Society of Clinical Oncology (ASCO), and Japanese Society for Cancer of the 
Colon and Rectum (JSCCR)  
2. Historical review of surveillance after curative resection for colorectal 
cancer 
2.1 Randomized controlled study 
The consensus on the optimal surveillance schedule after curative resection for colorectal 
cancer has not been established. Six randomized controlled trials (RCT) were reported to 
validate the usefulness of intensive surveillance after curative resection for colorectal cancer 
(Table 1).4-9 In all RCTs, there were no differences in recurrence rate between patients with 
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and without intensive follow-up. There was a description of time to recurrence after 
curative resection for colorectal cancer in three RCTs.4,5,7 Intensive surveillance led to earlier 
detection of recurrence in all three RCTs. As for curative resection rates of recurrent tumor, 
in three RCTs, intensive surveillance led to more frequent curative resection for recurrent 
tumor.4,7,9 On the other hand, in two RCTs, there were no differences in resection rates of 
recurrent tumor.5,6 Two RCTs disclosed the better survival in the intensive group,7,9 
although the majority of RCTs failed to show a survival benefit of intensive surveillance 
after curative resection for colorectal cancer.4-6,8 
2.2 Meta-analysis 
Although six RCTs have been conducted, all trials were underpowered or unsatisfactory. 
Therefore, three meta-analyses using the data of these RCTs evaluated the usefulness of 
intensive surveillance.10-12 There was no significant difference in recurrence rate between 
patients with intensive surveillance and those with non-intensive one. Renehan et al. 
reported that intensive surveillance led to earlier detection of recurrence after curative 
resection for colorectal cancer.12 Jeffery et al. clarified that intensive surveillance led to 
higher resection rate of recurrent tumor.11 In all meta-analyses, intensive surveillance 
improved survival after curative resection for colorectal cancer. 
3. Characteristics of recurrence after curative resection for colorectal cancer 
The Japanese Society for Cancer of the Colon and Rectum (JSCCR) organized the study 
group on post-surgical surveillance after curative resection for colorectal cancer in 2003. The 
data were collected from 14 institutions which were the members of JSCCR. The recurrence 
rate after curative resection for colorectal cancer was investigated according to the TNM 
stage and the recurrence site.3 The data of 5,230 patients who underwent curative resection 
for colorectal cancer from 1991 to 1996 were collected. Among 5,230 patients, 3,583 had 
colon cancer and 1,647 had rectal cancer. Among these, 906 patients (17.3%) developed a 
recurrence during the median surveillance of 6.6 years. The characteristics of patients are 
shown in Table 2. The recurrence rate was significantly higher in patients with rectal cancer 
(24.3%) than in those with colon cancer (14.1%, p<0.0001).  
3.1 Recurrence by TNM stage 
The recurrence rate in each stage was 3.7% in stage I, 13.3% in stage II, and 30.8% in stage III, 
respectively (p<0.0001). In each stage, the recurrence rate in patients with rectal cancer was 
higher than that in patients with colon cancer. The recurrence rates after curative resection 
for stage I, II, and III colon cancer were 2.7%, 12.1%, and 24.3%, respectively. Those after 
curative resection for stage I, II, and III rectal cancer were 5.7%, 16.7%, and 43.2%, 
respectively. The speed of recurrence in patients with stage I cancer was slow and constant 
(Figure 1a). On the other hand, the recurrence appeared rapidly within 3 years after curative 
resection for stage II and III colorectal cancer (Figure 1b and 1c). The cumulative appearance 
rates of recurrence at 3 years for stage I, II, and III were 68.6%, 76.9%, and 87.0%, 
respectively. Those at 5 years were 96.1%, 92.9%, and 97.8%, respectively. Recurrence after 5 
years was rare for all three stages: 0.14% (2/1367), 0.94% (18/1912), and 0.67% (13/1951), 
respectively. 
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Table 2. Characteristics of patients 
 
Fig. 1a. The cumulative appearance rate of recurrence after curative resection for stage I (a), 
stage II (b), and stage III (c) colorectal cancer. 
 
Fig. 1b. The cumulative appearance rate of recurrence after curative resection for stage I (a), 
stage II (b), and stage III (c) colorectal cancer. 
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Fig. 1c. The cumulative appearance rate of recurrence after curative resection for stage I (a), 
stage II (b), and stage III (c) colorectal cancer. 
An intensive surveillance program could be adopted in stage II and III patients for the first 3 
years and less intensive program for the next 2 years. Patients with stage I colorectal cancer 
could be followed less intensively. 
3.2 First recurrence site 
A study using autopsy reported that the most frequent metastatic site from colorectal cancer 
was the liver followed by the lung.13 This was consistent with our study (Table 3).3 The liver 
was the most frequent recurrent site after curative resection for colon cancer (7.0%). The 
second was the lung (3.5%). The local recurrence was most frequent after curative resection 
for rectal cancer (8.8%). The lung and the liver were the second and the third frequent 
metastatic sites. There was no difference in hepatic recurrence rate between patients with 
colon cancer and those with rectal cancer, while the pulmonary, local and anastomotic 
recurrence rates after curative resection for rectal cancer were significantly higher than those 
for colon cancer. In each recurrent site, approximately 80 to 90% of recurrence developed 
within 3 years (Figure 2). More than 95% of anastomotic recurrence was found within 3 
years after curative resection for colorectal cancer (Figure 2d). In 5 years after curative 
resection for colorectal cancer, more than 95% of recurrence was found in each recurrent site 
(Table 4). 
In this study, there was no patient with preoperative radiotherapy for rectal cancer. At 
present, the standard therapy for rectal cancer is total mesorectal excision with preoperative 
chemoradiotherapy in many countries.14-18 Six percent of the patients with preoperative 
combined modality therapy for rectal cancer followed by total mesorectal excision 
developed a recurrence over 5 years.19 In their study, of the 67 patients who developed 
recurrent disease, 4 (6%) had recurrent disease documented greater than 5 years following 
surgery. Three of these 4 patients had a distant recurrence, and 1 had both a local and 
distant recurrence. The recurrences were documented 61, 71, 76, and 96 months following 
curative rectal resection.  
Therefore, the surveillance after 5 years might be necessary if patients receive radiotherapy 
or adjuvant chemotherapy. 
www.intechopen.com
 
Contemporary Issues in Colorectal Surgical Practice 
 
94
 
Colon (%) 㻾㼑㼏㼠㼡㼙 㻔%㻕
Patients with
relapse
Patients with
relapse
Number of patients
506/3583 (14.1) 400/1647 (24.3) p<0.0001**
Gender 
Male 306/2066 (14.8) 253/1039 (24.4) p<0.0001**
Female 200/1517 (13.2) 147/608 (24.2) p<0.0001**
TNM stage
Stage I 24/891 (2.7) 27/476 (5.7) p = 0.0056**
Stage II 171/1410 (12.1) 84/502 (16.7) p = 0.0091**
Stage III 311/1282 (24.3) 289/669 (43.2) p<0.0001**
First recurrence site
Liver 252/3853 (7.0) 121/1647 (7.3) NS**
Lung 126/3583 (3.5) 124/1647 (7.5) p<0.0001**
Local 64/3583 (1.8) 145/1647 (8.8) p<0.0001**
Anastomotic 9/3583 (0.3) 13/1647 (0.8) p = 0.0052**
Others 130/3583 (3.6) 69/1647 (4.2) NS**
P  value*
 
* Recurrence rates in patients with colon cancer compared to those with rectal cancer, ** chi-square test, 
*** Mann-Whitney U test 
Table 3. Comparison of recurrence rates between patients with colon cancer and those with 
rectal cancer 
 
within 3 years within 4 years within 5 years
Liver 7.1 (373) 87.9 94.1 98.7
Lung 4.8 (250) 77.7 88.8 94.8
Local 4.0 (209) 81.1 90.3 96.1
Anastomotic 0.4 (22) 95.5 95.5 95.5
Others 3.8 (199) 79.8 91.4 95.5
First recurrence site
% recurrence (observed
recurrences /5230)
Cumulative appearance rate of recurrence (%)
 
Table 4. Recurrence rates by the initial recurrence site 
 
 
Fig. 2a. The cumulative appearance rate of recurrence in liver (a), lung (b), local (c), 
anastomosis (d), and others (e). 
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Fig. 2b. The cumulative appearance rate of recurrence in liver (a), lung (b), local (c), 
anastomosis (d), and others (e). 
 
Fig. 2c. The cumulative appearance rate of recurrence in liver (a), lung (b), local (c), 
anastomosis (d), and others (e). 
 
Fig. 2d. The cumulative appearance rate of recurrence in liver (a), lung (b), local (c), 
anastomosis (d), and others (e). 
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Fig. 2e. The cumulative appearance rate of recurrence in liver (a), lung (b), local (c), 
anastomosis (d), and others (e). 
3.3 Survival 
According to the Japanese data, the 5-year overall survival rates in patients with stage I, II, 
and III colon cancer were 92.8%, 85.5%, and 76.2%, respectively (Figure 3a). Those in 
patients with stage I, II, and III rectal cancer were 92.2%, 84.6%, and 62.0%, respectively 
(Figure 3b).3 These outcomes seem to be better than those of the patients in the Surveillance, 
Epidemiology, and End Results (SEER) population-based data from 1992 to 2004. According 
to the SEER data, the 5-year survival rates in patients with stage I, T3N0, and T4N0 colon 
cancer were 76.3%, 66.7%, and 55.0%, respectively.20 Those in patients with stage III colon 
cancer varied from73.7% (T1-2N1a) to 12.9% (T4bN2b).  
 
Fig. 3a. The overall survival curve after curative resection for cancer of the colon (a) and 
rectum (b). 
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Fig. 3b. The overall survival curve after curative resection for cancer of the colon (a) and 
rectum (b). 
In terms of rectal cancer, the 5-year overall survival rates in Japanese patients with stage I, II, 
and III rectal cancer were 92.2%, 84.6%, and 62.0%, respectively. According to the SEER 
data, the 5-year observed survival rates in patients with stage I, T3N0, and T4N0 rectal 
cancer were 77.6%, 64.0%, and 50.5%, respectively.21 As for stage III rectal cancer, the 5-year 
observed survival rates varied from 75.7% (T1N1a) to 12.3% (T4bN2b).  
In each stage, the prognosis of the Japanese patients with colorectal cancer was better than 
that of US patients. One of the possible reasons might be the difference of surveillance 
system after curative resection for colorectal cancer. The Japanese patients with curative 
resection for colorectal cancer usually receive more intensive surveillance to detect 
recurrence than the American patients. Another possible reason might be the difference of 
surgical technique. The Japanese surgeons usually perform central vascular ligation to 
dissect regional lymph node. Some European institutions adopt the similar technique called 
complete mesocolic excision with central ligation. Hohenberger et al. presented an excellent 
outcome of patients who underwent complete mesocolic excision with central ligation.22 
However, most institutions in the Western countries do not adopt this technique.23 
3.4 Resection for recurrence  
In our study, among the 906 patients with recurrence after curative resection for colorectal 
cancer, 379 (41.8&) underwent resection for recurrence with curative intent.3 The prognoses 
of patients with resection for recurrence were better than those without resection. The 5-year  
survival rates after initial colorectal surgery in patients with and without resection for 
hepatic, pulmonary, local, and anastomotic recurrence were 55% and 11% (p<0.0001), 68% 
and 13% (p<0.0001), 48% and 22% (P = 0.0002), and 53% and 0% (p = 0.0003), respectively 
(Figure 4). The 5-year survival rates after resection for hepatic, pulmonary, local, and 
anastomotic recurrence were 45%, 48%, 27%, and 33%, respectively. 
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Fig. 4a. The outcomes after initial colorectal surgery in patients with and without resection 
for recurrence of liver (A), lung (B), local (C), and anastomosis (D). 
 
 
 
Fig. 4b. The outcomes after initial colorectal surgery in patients with and without resection 
for recurrence of liver (A), lung (B), local (C), and anastomosis (D). 
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Fig. 4c. The outcomes after initial colorectal surgery in patients with and without resection 
for recurrence of liver (A), lung (B), local (C), and anastomosis (D). 
 
 
 
Fig. 4d. The outcomes after initial colorectal surgery in patients with and without resection 
for recurrence of liver (A), lung (B), local (C), and anastomosis (D). 
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3.5 Timing of recurrence 
Patients were classified into three groups according to the timing of recurrence (TR): TR≤1 
year, 1<TR≤3 years, 3 years<TR. The earlier the hepatic, pulmonary, and local recurrence, 
the poorer the survival after initial colorectal surgery (Figure 5).24 If patients had resection 
for recurrence, there was no difference in survival after recurrence according to the timing 
of recurrence (Figure 6). 
 
Fig. 5a. The overall survival curve after initial colorectal surgery according to the timing of 
recurrence. The later recurrence in liver (a), lung (b), and local (c) leads to the better 
survival. 
 
Fig. 5b. The overall survival curve after initial colorectal surgery according to the timing of 
recurrence. The later recurrence in liver (a), lung (b), and local (c) leads to the better 
survival. 
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Fig. 5c. The overall survival curve after initial colorectal surgery according to the timing of 
recurrence. The later recurrence in liver (a), lung (b), and local (c) leads to the better 
survival. 
 
 
 
Fig. 5d. The overall survival curve after initial colorectal surgery according to the timing of 
recurrence. The later recurrence in liver (a), lung (b), and local (c) leads to the better 
survival. 
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Fig. 6a. If the patients underwent curative resection for recurrence, the outcomes after 
recurrence were irrespective of the timing of recurrence. 
 
 
Fig. 6b. If the patients underwent curative resection for recurrence, the outcomes after 
recurrence were irrespective of the timing of recurrence. 
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Fig. 6c. If the patients underwent curative resection for recurrence, the outcomes after 
recurrence were irrespective of the timing of recurrence. 
 
Fig. 6d. If the patients underwent curative resection for recurrence, the outcomes after 
recurrence were irrespective of the timing of recurrence. 
4. Surveillance tools after curative resection for colorectal cancer 
In our study, the combination of symptoms, physical examination, and tumor marker 
detected the majority of recurrence in all sites except for lung (Table 5).3 In this section, the 
evidence for usefulness of each surveillance tool is discussed. 
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4.1 History and physical examination 
It is not rare that patients have a symptom at the time of recurrence after curative resection 
for colorectal cancer. According to the result of RCTs, 16% to 66% of patients had some sort 
of symptom.4,5 Therefore, periodical clinical visits seem to be important to detect a 
recurrence after curative resection for colorectal cancer. On the other hand, Ohlsson et al. 
reported that it was rare to detect a resectable recurrent tumor only history and physical 
examination.6  
4.2 CEA 
Carcinoembryonic antigen (CEA) is most widely used as tumor marker for colorectal cancer. 
The serum CEA level was high in the majority of patients with recurrence after curative 
resection for colorectal cancer.25 Especially, 80% of patients with hepatic recurrence from 
colorectal cancer had higher serum CEA levels.25 Graham et al. reported that serum CEA 
measurement was the most useful and economical surveillance tool to detect recurrence 
after curative resection for colorectal cancer.26 Therefore, serum CEA test was recommended 
as a surveillance tool after curative resection for colorectal cancer.10 
4.3 Chest X-ray 
It is controversial to use chest x-ray as a surveillance tool to detect recurrence after curative 
resection for colorectal cancer. Since chest x-ray can detect resectable pulmonary metastasis 
with probability of 1%,26,27 it is not recommended to use chest x-ray as a surveillance tool in 
many institutions. On the other hand, Ike et al. reported the good outcomes of 42 patients 
with curative resection for pulmonary recurrence which was detected by the combination of 
serum CEA test of every 2 months and chest x-ray of every 6 months.28 The 5-year survival 
rate after curative resection for pulmonary recurrence was 63.7%. 
4.4 CT scans 
Howell et al. reported that annual computed tomography (CT) scan could detect 87.5% of 
liver metastases at an asymptomatic stage,29 whereas, in total, only 2 cases out of 157 (1.3%) 
underwent curative resection for liver metastases. An RCT conducted by Schoemaker et al. 
clarified that abdominal CT scan increased the detection rate of liver metastases, although 
there was no difference in resection rate between the groups with and without CT scan.8 On 
the other hand, the UK group reported the usefulness of serum CEA measurement and CT 
scan in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.30 In 
their study, among 530 patients with stage II and III colorectal cancer, 154 had recurrence 
after adjuvant chemotherapy. Recurrences were detected by symptoms (n = 65), CEA (n = 
45), CT (n = 49), and others (n = 9). The CT-detected group had a better survival compared 
with the symptomatic group (P =.0046). 
Intensive surveillance after curative resection for colorectal cancer was not adopted in 
Western countries.31,32 However, since the results of meta-analyses revealed that intensive 
surveillance after curative resection for colorectal cancer contributed to better outcomes, 
routine use of CT scans has been recommended.33,34 
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4.5 PET scans 
The usefulness of positron-emission tomography (PET) in the detection of recurrence after 
curative resection for colorectal cancer is uncertain. Sobhani et al. reported a clinical trial 
that randomly assigned 130 patients with curative resection for colorectal cancer to the 
conventional surveillance group (periodic serum tumor marker, ultrasound, chest x-ray, and 
CT scans) and the PET-additional group.35 The PET scans were performed in 9 and 15 
months after surgery. Recurrences were detected after a shorter time (12.1 vs 15.4 months) in 
the PET group. Moreover, recurrences were more frequently cured by surgery (R0) in the 
PET group. The usefulness of PET scans in the detection of recurrence after curative 
resection for colorectal cancer should be clarified in a large-scale study. 
4.6 Colonoscopy 
Since the anastomotic recurrence rate after colectomy is low, the usefulness of periodical 
colonoscopy to detect anastomotic recurrence is skeptical.36 On the other hand, since the 
anastomotic recurrence rate after resection for rectal cancer is higher than that after resection 
for colon cancer, several studies reported the adequacy of periodical colonoscopy to detect 
anastomotic recurrence after surgery.31,37 At the same time, colonoscopy can find 
metachronous adenoma and cancer in the colon and rectum. Metachronous lesions develop 
in 1.5 to 3% of patients in the first 5 years after colorectal surgery.8,27,38-42 In Japan, the 
colonoscopy is usually performed one year after colorectal surgery and thereafter every two 
years. If total colonoscopy cannot be performed preoperatively because of the stenosis, it is 
recommended that the first colonoscopy should be performed three to six months after 
colorectal surgery.  
5. Recommended surveillance after curative resection for colorectal cancer 
from ESMO, ASCO, and JSCCR 
Both previous and present guidelines for surveillance after curative resection for 
colorectal cancer from ASCO and ESMO are shown in Table 6.31,33,34,43 Previously, neither 
ASCO nor ESMO recommended the intensive surveillance after curative resection for 
colorectal cancer, because most RCTs failed to show the prognostic significance of 
intensive surveillance.4-8 However, since three meta-analyses showed the effectiveness of 
intensive surveillance, these guidelines changed their attitude toward surveillance after 
curative resection for colorectal cancer. At present, both societies recommend periodical 
serum CEA measurement and CT. Periodical colonoscopy to detect metachronous 
adenoma and cancer is also recommended. 
In Japan, JSCCR published the first edition of guidelines for the treatment of colorectal 
cancer in 2005 and the second edition in 2009. The Japanese institutions adopted more 
intensive surveillance to detect recurrence after curative resection for colorectal cancer. The 
recommended surveillance schedule in the Japanese guidelines is shown in the Table 7. 
On the other hand, the optimal schedule and modality to detect recurrence after curative 
resection for colorectal cancer are still uncertain. These issues should be clarified by RCTs in 
future. 
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6. Summary 
i. The most frequent site of recurrence after curative resection for colon cancer is the liver. 
The second is the lung.  
ii. The most frequent site of hematogenous recurrence after curative resection for rectal 
cancer is the lung. The second is the liver. 
iii. The recurrence rate in rectal cancer is higher than in colon cancer. 
iv. Approximately 80 to 90% of recurrence after curative resection for colorectal cancer 
developed within 3 years. 
v. In any recurrent sites, the prognosis of patients with curative resection for recurrence 
was better than that of patients without curative resection for recurrence. 
vi. The later the recurrence, the better the survival. 
vii. If patients undergo curative resection for recurrence, the prognosis after resection for 
recurrence is irrespective of timing of recurrence. 
viii. Although the optimal surveillance tools and schedule are uncertain, the intensive 
surveillance leads to better survival after curative resection for colorectal cancer 
compared to the non-intensive one. 
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